Geode Capital Management’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.79M | Buy |
|
|||||
|
2025
Q1 | $7.4M | Buy |
|
|||||
|
2024
Q4 | $6.76M | Buy |
|
|||||
|
2024
Q3 | $6.47M | Buy |
|
|||||
|
2024
Q2 | $3.21M | Buy |
|
|||||
|
2024
Q1 | $5.61M | Buy |
|
|||||
|
2023
Q4 | $5.36M | Buy |
|
|||||
|
2023
Q3 | $3.83M | Buy |
|
|||||
|
2023
Q2 | $4.4M | Buy |
|
|||||
|
2023
Q1 | $4.32M | Buy |
|
|||||
|
2022
Q4 | $4.72M | Buy |
|
|||||
|
2022
Q3 | $3.64M | Buy |
|
|||||
|
2022
Q2 | $3.47M | Buy |
|
|||||
|
2022
Q1 | $9.15M | Sell |
|
|||||
|
2021
Q4 | $8.25M | Buy |
|
|||||
|
2021
Q3 | $11.3M | Buy |
|
|||||
|
2021
Q2 | $12.9M | Buy |
|
|||||
|
2021
Q1 | $9.55M | Buy |
|
|||||
|
2020
Q4 | $9.1M | Buy |
|
|||||
|
2020
Q3 | $6.13M | Buy |
|
|||||
|
2020
Q2 | $4.57M | Buy |
|
|||||
|
2020
Q1 | $3.8M | Buy |
|
|||||
|
2019
Q4 | $4.83M | Sell |
|
|||||
|
2019
Q3 | $4.37M | Buy |
|
|||||
|
2019
Q2 | $6.03M | Buy |
|
|||||
|
2019
Q1 | $5.22M | Buy |
|
|||||
|
2018
Q4 | $4.44M | Buy |
|
|||||
|
2018
Q3 | $5.29M | Buy |
|
|||||
|
2018
Q2 | $4.66M | Buy |
|
|||||
|
2018
Q1 | $4.51M | Buy |
|
|||||
|
2017
Q4 | $4.85M | Buy |
|
|||||
|
2017
Q3 | $2.67M | Buy |
|
|||||
|
2017
Q2 | $2.81M | Buy |
|
|||||
|
2017
Q1 | $3.35M | Buy |
|
|||||
|
2016
Q4 | $1.81M | Sell |
|
|||||
|
2016
Q3 | $2.95M | Buy |
|
|||||
|
2016
Q2 | $1.67M | Buy |
|
|||||
|
2016
Q1 | $1.52K | Buy |
|
|||||
|
2015
Q4 | $1.99M | Buy |
|
|||||
|
2015
Q3 | $1.43M | Buy |
|
|||||
|
2015
Q2 | $1.76M | Buy |
|
|||||
|
2015
Q1 | $1.93M | Buy |
|
|||||
|
2014
Q4 | $1.04M | Buy |
|
|||||
|
2014
Q3 | $855K | Buy |
|
|||||
|
2014
Q2 | $1.59M | Buy |
|
|||||
|
2014
Q1 | $1.68M | Buy |
|
|||||
|
2013
Q4 | $1.2M | Buy |
|
|||||
|
2013
Q3 | $1.49M | Buy |
|
|||||
|
2013
Q2 | $1.19M | Buy |
|